(Q34777672)

English

AIDS dementia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

AIDS dementia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

0 references

author name string

David B Clifford

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Medical Clinics of North America

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

86

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

537-50, vi

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

AIDS — The First 20 Years

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

The AIDS dementia complex: I. Clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Changes to AIDS dementia complex in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

AIDS does not alter the total number of neurons in the hippocampal formation but induces cell atrophy: a stereological study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Neocortical damage during HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Neuronal loss in the frontal cortex in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Morphometry, histopathology, and tomography of cerebral atrophy in the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Preferential loss of large neocortical neurons during HIV infection: a study of the size distribution of neocortical neurons in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Varicella-zoster virus encephalitis in acquired immunodeficiency syndrome: report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Pathways to neuronal injury and apoptosis in HIV-associated dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

The metabolic pathology of the AIDS dementia complex

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

HIV in the brain: RNA levels and patterns of zidovudine resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Cytokines in the brain during viral infection: clues to HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Unique monocyte subset in patients with AIDS dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

HIV infection and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Cytomegalovirus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: A proton magnetic resonance spectroscopic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Perfusion MRI detects rCBF abnormalities in early stages of HIV-cognitive motor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Indinavir-based treatment of HIV-1 infected patients: efficacy in the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Neuronal injury associated with HIV-1: approaches to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

A phase I/II trial of nimodipine for HIV-related neurologic complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0025-7125(02)00005-6

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34777672&oldid=1561661617"